Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is a clinical-stage biotechnology company applying its proprietary Anticalin technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Anticalins … Continue reading →

Celsion Corp. (NASDAQ: CLSN), a fully integrated oncology company, is focused on developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies. The company’s lead program is ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, … Continue reading →

Lingo Media Corp. (OTC: LMDCF) is an EdTech company that focuses on online and print-based technologies that aid in the teaching of English through its two distinct business units: ELL Technologies and Lingo Learning. ELL Technologies is a global English … Continue reading →

Data I/O Corp. (NASDAQ: DIOD) is a global provider of manual and automated device programming systems for flash, microcontroller and logic devices. The company serves electronics manufacturers around the world including OEM, ODM, EMS and programming centers. Its programming systems … Continue reading →

The Female Health Company (NASDAQ: FHCO) produces and markets the FC2 Female Condom® (FC2). The company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in a number of countries that cover key aspects … Continue reading →

NanoViricides, Inc. (NYSE: NNVC) is a nano-biopharmaceutical company focused on discovering, developing, and marketing therapeutics for the treatment of viral infections. The company is developing anti-flu drug candidates at pre-clinical and advanced pre-clinical stage. These candidates include two FluCide drugs … Continue reading →

Relmada Therapeutics, Inc. (OTC: RLMD) is a clinical-stage specialty pharmaceutical company developing novel versions of proven drug products as well as new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The company’s … Continue reading →

Semler Scientific, Inc. (NASDAQ: SMLR) provides diagnostic and testing services to healthcare insurers and physician groups. Its mission is to develop, manufacture and market innovative proprietary products and services that assist healthcare providers in evaluating and treating chronic diseases. The … Continue reading →

iCAD, Inc. (NASDAQ: ICAD) delivers innovative cancer detection, radiation therapy solutions, and management services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. iCAD offers a variety of upgradeable, computer aided detection (CAD) and … Continue reading →

Biosyent, Inc. (OTC: BIOYF) is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. … Continue reading →